K-ATP opener-mediated attenuation of spontaneous bladder contractions in ligature-intact, partial bladder outlet obstructed rats

Life Sciences

Volumn 72, Issue 17, 2003, Pages 1931-1941

  Lynch III, James J ^a   Brune, Michael E ^a   Lubbers, Nathan L ^a   Coghlan, Michael J ^b   Cox, Bryan F ^a   Polakowski, James S ^a   King, Linda L ^a   Sullivan, James P ^a   Brioni, Jorge D ^a  

^a ABBOTT LABORATORIES   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Animal model; Bladder outlet obstruction; Detrusor instability; Heart rate; K ATP channel opener; Mean arterial pressure; Overactive bladder; Rat; Spontaneous bladder contractions; Urinary incontinence

Indexed keywords

4 [3,4 DIOXO 2 (1,2,2 TRIMETHYLPROPYLAMINO) 1 CYCLOBUTENYLAMINO] 3 ETHYLBENZONITRILE; A 278637; ADENOSINE TRIPHOSPHATE; N (4 BENZOYLPHENYL) 3,3,3 TRIFLUORO 2 HYDROXY 2 METHYLPROPIONAMIDE; POTASSIUM CHANNEL STIMULATING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFACT; BLADDER CATHETERIZATION; BLADDER CONTRACTION; BLADDER NECK STENOSIS; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; DISEASE MODEL; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG EFFICACY; DRUG SELECTIVITY; FEMALE; HEART RATE; LIGATION; MEAN ARTERIAL PRESSURE; NONHUMAN; RAT;

ANIMALIA;

EID: 0037436731     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(03)00091-2     Document Type: Article

References (35)

1. Pandita R.K., Fujiwara M., Alm P., Andersson K.-E. Cystometric evaluation of bladder function in non-anesthetized mice with and without bladder outlet obstruction. Journal Urology. 164:2000;1385-1389.
2. Mattiasson A., Uvelius B. Changes in contractile properties in hypertrophic rat urinary bladder. Journal Urology. 128:1982;1340-1342.
3. Malmgren A., Sjogren C., Uvelius B., Mattiasson S., Andersson K.-E., Andersson P.O. Cystometrical evaluation of bladder instability in rats with infravesical outflow obstruction. Journal Urology. 137:1987;1291-1294.
4. Kato K., Wein A.J., Kitada S., Haugaard N., Levin R.M. The functional effect of mild outlet obstruction on the rabbit urinary bladder. Journal Urology. 140:1988;880-884.
5. Radzinski C., McGuire J., Smith D., Wein A.J., Levin R.M., Miller L.F., Elbadawi A. Creation of a feline model of obstructive uropathy. Journal Urology. 145:1991;859-863.
6. Azadzoi K.M., Pontari M., Vlachiotis J., Siroky M.B. Canine bladder blood flow and oxygenation: Changes induced by filling, contraction and outlet obstruction. Journal Urology. 155:1996;1459-1465.
7. Sibley G.N.A. An experimental model of detrusor instability in the obstructed pig. British Journal Urology. 57:1985;292-298.
8. Shieh C.-C., Coghlan M., Sullivan J.P., Gopalakrishnan M. Potassium channels: molecular defects, diseases, and therapeutic opportunities. Pharmacological Reviews. 52:2000;557-593.
9. Hedlund H., Mattiasson A., Andersson K.-E. Effects of pinacidil on detrusor instability in men with bladder outlet obstruction. Journal Urology. 146:1991;1345-1347.
10. Komersova K., Rogerson J.W., Conway E.L., Lim T.C., Brown D.J., Krum H., Jackman G.P., Murdoch R., Louis W.J. The effect of levcromakalim (BRL 38227) on bladder function in patients with high spinal cord lesions. British Journal Clinical Pharmacology. 39:1995;207-209.
11. Malmgren A., Andersson K.-E., Sjogren C., Andersson P.O. Effects of pinacidil and cromakalim (BRL 34915) on bladder function in rats with detrusor instability. Journal Urology. 142:1989;1134-1138.
12. Wojdan A., Freeden C., Woods M., Oshiro G., Spinelli W., Colatsky T.J., Sheldon J.H., Norton N.W., Warga D., Antane M.M., Antane S.A., Butera J.A., Argentieri T.M. Comparison of the potassium channel openers, WAY-133537, ZD6169, and celikalim on isolated bladder tissue and in vivo bladder instability in rat. Journal Pharmacology Experimental Therapeutics. 289:1999;1410-1418.
13. Brune M.E., Fey T.A., Brioni J.D., Sullivan J.P., Williams M., Carroll W.A., Coghlan M.J., Gopalakrishnan M. (-)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b] quinolin-8(4H)-one 1,1-dioxide (A-278637): a novel ATP-sensitive potassium channel opener efficacious in suppressing urinary bladder contractions. II. In vivo characterization. Journal Pharmacology Experimental Therapeutics. 303:2002;387-394.
14. Payne C.K. Epidemiology, pathophysiology, and evaluation of urinary incontinence and overactive bladder. Urology. 51(Suppl. 2A):1998;3-10.
15. Resnick N.M., Yalla S.V., Laurino E. The pathophysiology of urinary incontinence among institutionalized elderly persons. New England Journal Medicine. 320:1989;1-7.
16. Wagner T.H., Hu T.W. Economic costs of urinary incontinence in 1995. Urology. 51:1998;355-361.
17. Tsang K.K., Garraway W.M. Prostatism and the burden of benign prostatic hyperplasia on elderly men. Age Aging. 23:1994;360-364.
18. Andersson K.-E., Appell R., Cardozo L.D., Chapple C., Drutz H.P., Finkbeiner A.E., Haab F., Vela Navarrete R. The pharmacological treatment of urinary incontinence. British Journal Urology International. 84:1999;923-947.
19. de Groat W.C., Yoshimura N. Pharmacology of the lower urinary tract. Annual Review Pharmacology Toxicology. 41:2001;691-721.
20. Madersbacher H., Halaska M., Voight R., Alloussi S., Hofner K. A placebo-controlled, multicentre study comparing the tolerability and efficacy of propiverine and oxybutynin in patients with urgency and urge incontinence. British Journal Urology International. 84:1999;646-651.
21. Truss M.C., Becker A.J., Uckert S., Schultheiss D., Machtens S., Jonas U., Stief C.G. Selective pharmacological manipulation of the smooth muscle tissue of the genitourinary tract: a glimpse into the future. British Journal Urology International. 83:1999;36-41.
22. Larsson G., Hallen B., Nilvebrant L. Tolterodine in the treatment of overactive bladder: analysis of the pooled Phase II efficacy and safety data. Urology. 53:1999;990-998.
23. Gopalakrishnan M., Buckner S.A., Whiteaker K.L., Shieh C.-C., Molinari E.J., Milicic I., Daza A.V., Davis-Taber R., Scott V.E., Sellers D., Chess-Williams R., Chapple C.R., Liu Y., Liu D., Brioni J.D., Sullivan J.P., Williams M., Carroll W.A., Coghlan M.J. (-)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b] quinolin-8(4H)-one 1,1-dioxide (A-278637): a novel ATP-sensitive potassium channel opener efficacious in suppressing urinary bladder contractions. I. In vitro characterization. Journal Pharmacology Experimental Therapeutics. 303:2002;379-386.
24. Guarneri L., Ibba M., Angelico P., Testa R. Effects of oxybutynin, terodiline, and nifedipine on the cystometrogram in conscious rats with infravesical outflow obstruction. Pharmacological Research. 24:1991;263-272.
25. Yoshimura N., de Groat W.C. Increased excitability of afferent neurons innervating rat urinary bladder after chronic bladder inflammation. Journal Neuroscience. 19:1999;4644-4653.
26. ATP channel opener, on bladder hyperactivity and spinal c-fos expression evoked by bladder irritation in rats. Brain Research. 807:1998;11-18.
27. ATP channel opener on cyclophosphamide induced cystitis in awake rats. Abstracts Society Neuroscience. 25:1999;1686.
28. ATP channel opener, on the micturition reflex in the rat. Journal Pharmacology Experimental Therapeutics. 290:1999;825-831.
29. Lluel P., Duquenne C., Martin D. Experimental bladder instability following bladder outlet obstruction in the female rat. Journal Urology. 160:1998;2253-2257.
30. O'Connor L.T. Jr., Vaughan E.D. Jr., Felsen D. In vivo cystometric evaluation of progressive bladder outlet obstruction in rats. Journal Urology. 158:1997;631-635.
31. Damaser M., Arner A., Uvelius B. Partial outlet obstruction induces chronic distension and increased stiffness of rat urinary bladder. Neurourology Urodynamics. 15:1996;650-665.
32. Pandita R.K., Andersson K.-E. Effects of intravesical administration of the K+ channel opener, ZD6169 in conscious rats with and without bladder outflow obstruction. Journal Urology. 162:1999;943-948.
33. Malmgren A., Sjogren C., Andersson K.E., Andersson P.O. Effects of atropine on bladder capacity and instability in rats with bladder hypertrophy. Neurourology Urodynamics. 6:1987;331-338.
34. A.C. Fabiyi, M. Gopalakrishnan, J.J. Lynch III, J.D. Brioni, M.J. Coghlan, M.E. Brune, In vivo evaluation of the potency and bladder-vascular selectivity of the ATP-sensitive potassium channel openers (-)-cromakalim, ZD6169 and WAY-133537 in rats. British Journal Urology International (in press).
35. Kwak T.I., Lee J.G. Inhibitory effects of propiverine, atropine and oxybutynin on bladder instability in rats with infravesical outlet obstruction. British Journal Urology. 82:1998;172-277.